BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND CANT1, ENSG00000171302, 124583, Q8WVQ1, SHAPY, SCAN-1 AND Diagnosis
7 results:

  • 1. [A Case of Primary Liposarcoma of Pancreas Difficult to Diagnose Preoperatively].
    Suzuki A; Matsui H; Tokumitsu Y; Shindou Y; Matsukuma S; Nakajima M; Tomochika S; Yoshida S; Iida M; Suzuki N; Takeda S; Yoshino S; Hazama S; Nagano H
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):1921-1923. PubMed ID: 33468873
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Value of LSR and ADCs in differential diagnosis of hilar and mediastinal lymph nodes in lung cancer].
    Cai RF; Cui L; Yin JB; Jiang JQ; Liu J
    Zhonghua Yi Xue Za Zhi; 2018 Oct; 98(37):3009-3013. PubMed ID: 30392258
    [No Abstract]    [Full Text] [Related]  

  • 3. diagnosis of recurrent prostate cancer with PET/CT imaging using the gastrin-releasing peptide receptor antagonist
    Wieser G; Popp I; Christian Rischke H; Drendel V; Grosu AL; Bartholomä M; Weber WA; Mansi R; Wetterauer U; Schultze-Seemann W; Meyer PT; Jilg CA
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(9):1463-1472. PubMed ID: 28417160
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Indolent, Potentially Inconsequential lung cancers in the Pittsburgh lung Screening Study.
    Thalanayar PM; Altintas N; Weissfeld JL; Fuhrman CR; Wilson DO
    Ann Am Thorac Soc; 2015 Aug; 12(8):1193-6. PubMed ID: 26107281
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Dual time point positron emission tomography/computed tomography scan in evaluation of intrathoracic lesions in an area endemic for histoplasmosis and with high prevalence of sarcoidosis.
    Kadaria D; Archie DS; SultanAli I; Weiman DS; Freire AX; Zaman MK
    Am J Med Sci; 2013 Nov; 346(5):358-62. PubMed ID: 23276900
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancer.
    Everitt S; Herschtal A; Callahan J; Plumridge N; Ball D; Kron T; Schneider-Kolsky M; Binns D; Hicks RJ; MacManus M
    Cancer; 2010 Nov; 116(21):5030-7. PubMed ID: 20623786
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.
    Uesaka D; Demura Y; Ishizaki T; Ameshima S; Miyamori I; Sasaki M; Fujibayashi Y; Okazawa H
    J Nucl Med; 2008 Oct; 49(10):1606-12. PubMed ID: 18794269
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.